Results

Total Results: over 10,000 records

Showing results for "treatment".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
    February 24, 2016 - , group counseling, family behavior therapy, cognitive-behavioral therapy, and assessment and Source … care, including the types of interventions used (specifics of pharmacological and nonpharmacological treatments … Concurrent/prior treatments vi.   Length of followup vii.   Outcomes measured viii.   … Slow-release oral morphine as maintenance therapy for opioid dependence. … Pharmacological therapies for maintenance treatments of opium dependence.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
    April 01, 2016 - How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD … summarize, interventions included for one or more of the key questions (KQs) are: • Nonpharmacologic therapies … Key Question 5: How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments … How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD differ … How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD differ
  3. digital.ahrq.gov/ahrq-funded-projects/developing-passive-digital-marker-prediction-childhood-asthma-treatment
    July 31, 2025 - Developing a Passive Digital Marker for the Prediction of Childhood Asthma Treatment Response … for an initial diagnosis—the “incident case”—is unknown, hence the widespread use of therapeutic trials … to determine an evidence-based treatment strategy. … , including more proactive and personalized treatment, for improved patient-centered outcomes. … when applied to risk and prognostic EHR data derived from incident asthma cases exposed to first-line treatments
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
    September 30, 2010 - (Needham, Mass ) The Adjustable Continence Therapy (ACT®) The Adjustable Continence Therapy (ACT®) Uromedica … What are the harms from pharmacologic treatments when compared with no active treatment? 4. … What are the harms from nonpharmacologic treatments when compared with no active treatment? 5. … treatment, education, behavioral therapy, biofeedback, bladder retraining (Kegel exercises), electrical … Eligible interventions of drug therapies or nonsurgical treatments.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
    January 01, 2014 - The added benefit of these therapies to standard care with compression and debridement also remains … The initial goal was to examine three of the major therapeutic interventions used in ulcer care in a … Variations in patient characteristics might influence assignment of therapeutic interventions. … Studies to evaluate sequential therapy should have a standardized approach to the sequential treatment … Dose Drug: Nexagon® Vehicle Estimated enrollment: 300 Sponsor OR PI and Collaborator(s): CoDa Therapeutics
  6. psnet.ahrq.gov/web-mm/treatment-challenges-after-discharge
    January 03, 2017 - Treatment Challenges After Discharge. PSNet [internet]. … Treatment Challenges After Discharge. PSNet [internet]. … process include adverse drug events, nosocomial infections, procedural complications, and diagnostic and therapeutic … discharge are common and include adverse drug events, nosocomial infections, procedural complications, and therapeuticTreatment Challenges After Discharge. PSNet [internet].
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
    May 01, 2013 - Does the effectiveness of treatments vary by use of exercise and medical therapy prior to invasive … currently in use (such as specific components of treatments considered to be “optimal medical therapy … However, the comparisons of all active treatments with each other showed that none of the treatments … benefit of therapies. … Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
    July 19, 2013 - • Transport from the ICU for diagnostic or therapeutic procedures • Previous antibiotic exposure, … These factors are essential to understanding and choosing an effective therapeutic regimen, and they … Equivalency OR Absorption OR Distribution OR Metabolism OR Excretion OR Protein Binding OR Therapeutic … Index OR Trough OR Peak OR Therapeutic Drug Monitoring) Pharmacodynamics (Terms for Pharmacodynamic … Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/bipolar-disorder-treatment_research-protocol.pdf
    June 23, 2014 - We separated physically-based somatic treatments, such as electroconvulsive therapy, into a third category … How do pharmacologic treatments (monotherapy or combination therapies) affect patient centered outcomes … How do pharmacologic treatments (monotherapy or combination therapies) affect patient centered outcomes … How do somatic treatments (electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS)) … and social rhythm therapy • Psychoeducation • Chronotherapy Somatic treatment treatment • Electroconvulsive
  10. integrationacademy.ahrq.gov/news-and-events/news/substance-use-disorder-treatment-month-january-inaugural-event
    January 08, 2025 - Whole-Person Care Age 0-5 Behavioral-Developmental Health Low-Threshold Treatment … SAMHSA also recently published reports related to substance use and its treatment including an issue … use treatment services. … For further reading on substance use disorder treatment, refer to the Academy’s Literature Collection … Individuals seeking treatment should use the FindTreatment.gov website to locate services near them
  11. integrationacademy.ahrq.gov/news-and-events/news/engagement-and-retention-nonabstinent-patients-sud-treatment-new-asam-clinical
    December 20, 2024 - , and buprenorphine treatment for individuals using high-potency synthetic opioids. … Do not require abstinence as a condition of treatment initiation or retention. … Only administratively discharge patients from treatment as a last resort. … Build connections to people with substance use disorder who are not currently seeking treatment. … Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions.
  12. integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/obtain-training-and-support-providers-and-staff/clinicwide-orientation-oud-treatment
    January 01, 2019 - Integrating Behavioral Health and Primary Care Playbook Medication-Assisted Treatment … Educate staff about MAT as a treatment approach, emphasizing that it is a “whole-person” approach that … Show them the research that demonstrates it can reduce opioid use, increase retention in treatment, and … Strengthening Treatment Access & Retention—State Implementation (STAR-SI). N.d.  … Principles of Substance Use Treatment Delivering Effective, Low Barrier Treatment
  13. effectivehealthcare.ahrq.gov/products/urinary-incontinence-treatment/research
  14. effectivehealthcare.ahrq.gov/products/treatment-resistant-depression/research
  15. effectivehealthcare.ahrq.gov/products/anal-cancer-treatment/research
  16. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/bacteremia-slides.pptx
    November 01, 2019 - Best Practices in the Diagnosis and Treatment of Bacteremia Best Practices in the Diagnosis and Treatment … Can I narrow therapy or change from IV to oral therapy? … Traditional treatment duration has been 10–14 days Randomized controlled trial including 604 patients … Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia. … Treatment options for carbapenem-resistant Enteriobacteriaceae infections.
  17. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/bacteremia-facilitator-guide.pdf
    November 01, 2019 - Best Practices in the Diagnosis and Treatment of Bacteremia AHRQ Safety Program for Improving … for their entire treatment duration versus 739 patients who were transitioned to oral step-down therapy … Data do not support the use of combination therapy over monotherapy for the treatment of Pseudomonas … Slide 20 S. aureus Bacteremia: Duration of Therapy SAY: All durations of therapy for Staph … Treatment is not needed for contaminants.
  18. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/sepsis-facilitator-guide.pdf
    November 01, 2019 - Best Practices in the Diagnosis and Treatment of Sepsis AHRQ Safety Program for Improving Antibiotic … No. 17(20)-0028-EF November 2019 Best Practices in the Diagnosis and Treatment of Sepsis … Acute Care Slide Title and Commentary Slide Number and Slide Best Practices in the Diagnosis and Treatment … Sepsis Acute Care SAY: This presentation will address best practices in the diagnosis and treatment … SAY: Before making recommendations about possible combination treatment regimens, it is helpful
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
    January 01, 2017 - Treatments for Schizophrenia in Adults: A Systematic Review Evidence Summary Condition and Treatment … Psychosocial and other nonpharmacological treatments include: assertive community treatment, cognitive … regardless of the length of the followup period, but that the type of intervention (psychoeducation or therapeutic … Defining empirically supported therapies. J Consult Clin Psychol. 1998 Feb;66(1):7-18. … Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia.
  20. effectivehealthcare.ahrq.gov/products/glaucoma-treatment/research-protocol